Mr. Mitchell Geisler reports

LEVELJUMP CLOSES NON-BROKERED PRIVATE PLACEMENT

Further to its news release of April 7, 2026, Leveljump Healthcare Corp. has closed, effective as of April 16, 2026, a non-brokered private placement through the issuance of 14.38 million common shares at a price of five cents per offered share in the capital of the company for gross proceeds of $719,000.

All securities issued and issuable in connection with the offering will be subject to a four-month-plus-one-day hold period ending Aug. 17, 2026. The offering has received conditional acceptance from the TSX Venture Exchange but remains subject to receipt of final acceptance.

In connection with the offering, the company has paid certain qualified finders the following: (i) cash finders' fees equal to 7 per cent of the gross proceeds raised from subscribers introduced to the company by the finders; and (ii) non-transferable finder warrants equal in number to 7 per cent of the number of offered shares issued to subscribers introduced to the company by the finder. Each finder warrant entitles the finder to purchase one common share in the capital of the company at a price of five cents per share for a period of two years following the closing of the offering. in total, the company paid $10,150 in finders' fees and issued 203,000 non-transferable finder warrants.

The net proceeds from the offering will be used for general working capital purposes. All offered shares were placed with arm's-length parties.

About Leveljump Healthcare Corp.

Leveljump Healthcare provides telehealth solutions to client hospitals and imaging centres through its teleradiology division as well as in-person radiology services through its diagnostic centres. Leveljump Healthcare focuses primarily on critical care for urgent and emergency patients, establishing integral relationships in the communities the company serves.

We seek Safe Harbor.